INTRODUCTION 42
Haemophilus ducreyi is a gram-negative bacterium that causes the sexually transmitted 43 genital ulcer disease chancroid, which has been shown to facilitate the transmission of HIV (47, 44 51). During human infection, H. ducreyi is surrounded by professional phagocytes and is subject 45 to attack by these and other components of a robust innate immune response (7, 8) . Some of the 46 major virulence factors of H. ducreyi are those that allow the organism to circumvent the innate 47 immune system. For example, the secreted proteins LspA1 and LspA2 are key to resisting 48 phagocytosis, and the outer membrane protein DsrA confers resistance to killing by human 49 serum (17, 24). Although little is known about how H. ducreyi regulates virulence factors, DsrA 50
and LspA2, along with secretory protein LspB, are controlled by the CpxRA two-component 51
regulator (29, 48). H. ducreyi lacking the sensor kinase component, cpxA, is attenuated in a 52
human model of infection, possibly because of dysregulation of important virulence determinants 53 (48). Thus, the CpxRA regulon plays a critical role in the pathogenesis of H. ducreyi infection. 54
During human disease, H. ducreyi is surrounded by antimicrobial peptide (AP)-secreting 55
cells, including neutrophils and macrophages (7, 8, 10) . APs are small, cationic peptides that aid 56 in the killing of microorganisms through membrane disruption or effects on intracellular targets 57 (14). APs play a protective role by controlling bacterial infection; however, successful 58 5 resistance cassettes, appropriate antibiotics, including spectinomycin (200 µg/ml), kanamycin 88 (20 µg/ml) or streptomycin (100 µg/ml) (35). For antimicrobial assays, strains were grown in 89
Columbia broth supplemented with hemin (50 µg/ml) (Aldrich Chemical Co., Milwaukee, WI), 90 5% heat inactivated fetal bovine serum (HyClone, Logan, UT), and 1% IsoVitalex and 91 supplemented with half the concentration of appropriate antibiotics. E. coli strains were grown 92 at 37°C in Luria-Bertani broth with appropriate antibiotics, including spectinomycin (50 µg/ml), 93 ampicillin (50 µg/ml), kanamycin (50 µg/ml), or streptomycin (100 µg/ml), except for strain 94 DY380, which was grown in L-Broth at 32°C or 42°C as indicated (48, 50) . 95
Construction and characterization of a nonpolar, unmarked mtrC deletion mutation 96 in H. ducreyi. We used "recombineering" to generate a mtrC deletion mutant, as described (48, 97
50). This method allows for the deletion of the mtrC gene, leaving a 35-codon open reading 98
frame that includes the last 7 codons of the mtrC gene (48). Briefly, a 3.8 kb PCR product 99 containing mtrC was amplified from 35000HP genomic DNA with primers mtrcfor1 and 100 mtrcrev1 (Table 2) and cloned into pGEM-T-Easy (Promega, Madison, WI) to generate 101 pMEB144. E. coli strain DY380 was transformed with pMEB144 and maintained at 32°C to 102 generate MEB149. MEB149 was grown to mid logarithmic phase and incubated at 42°C for 15 103 min to induce the lambda red recombinase, then transformed with a 2.2 kb PCR fragment 104 containing a spectinomycin resistance (Spec R ) cassette flanked by flippase (FLP) recognition 105 target (FRT) sites and 50 bp flanking mtrC that had been amplified from pRSM2832 with 106 primers H1P1mtrc and H2P2mtrc (48). Recombination in MEB149 replaced mtrC with the 107 FRT-Spec R -FRT cassette. A plasmid with the correct digestion pattern (pMEB191) was 108 digested with SpeI to generate a 4.5 kb fragment containing the recombined mtrC locus, which 109 was ligated into the suicide plasmid pRSM2072 to generate pMEB193. pMEB193 was passaged 110 6 through E. coli HB101 before H. ducreyi transformation. 111 35000HP was transformed with 3.6 µg of pMEB193 and screened for Spec R . Twenty-112 seven colonies were subcultured onto chocolate agar plates containing spectinomycin and 5-113 bromo-4-chloro-3-indolyl-β-D-galactopyranoside (Roche, Indianapolis, Ind.) (40 µg/ml). White 114 colonies were tested by colony PCR for the insertion of the Spec R cassette in the mtrC locus. A 115 clone with the correct insert was transformed with pRSM2975, a temperature sensitive plasmid 116 containing FLP recombinase under control of the tet promoter (50). Transformants were selected 117 on chocolate agar supplemented with kanamycin and cultured at 32°C, to maintain pRSM2975. 118
Expression of the FLP recombinase was induced with anhydrotetracycline (Clontech, Mountain 119
View, CA) in mid-logarithmic phase, and the culture was plated on chocolate agar plates and 120 grown at 35°C to promote the loss of pRSM2975. Colonies were replica plated on plates 121 containing spectinomycin, kanamycin, or no antibiotic to screen for the FRT recombination 122 event and the loss of pRSM2975. Of 89 colonies screened, recombination at the FRT site 123 occurred in 1 colony, and loss of the recombinase plasmid occurred in 21 of 89 colonies. 124
Because no colonies screened were sensitive to both spectinomycin and kanamycin, the 125 spectinomycin-sensitive colony was grown at 35°C for 48 hours on plates without antibiotics to 126 obtain a kanamycin-sensitive derivative that had lost pRSM2975; the clone was named 127
35000HPmtrC. 128
The desired construct in 35000HPmtrC was confirmed by PCR and sequencing. Growth 129 curves indicated no significant changes in growth rates compared with the parent strain (data not 130 were analyzed by agarose gel electrophoresis following RT-PCR to evaluate DNA 181 contamination. Reactions were carried out with the one-step QuantiTect SYBR Green RT-PCR 182 kit (Qiagen), and the Pfaffl method was used to determine the relative quantification of the target 183 gene compared to the constitutively expressed gyrB (gene ID HD1643), as a reference (36 
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Preliminary studies showed that the CCCP diluent DMSO had no effect on H. ducreyi survival or 204 on AP activity against H. ducreyi (data not shown). Upon challenge with APs, CCCP-treated H. 205 ducreyi was more susceptible than DMSO-treated H. ducreyi to both LL-37 (Fig. 1A) and human 206 β-defensin 3 (HBD-3) (Fig. 1B) . In contrast, CCCP treatment had no effect on survival in the 207 presence of the α-defensin human neutrophil peptide 2 (HNP-2) (data not shown). These data 208
show that H. ducreyi contains a PMF-dependent mechanism for resistance to LL-37 and β-209 defensins but not α-defensins. 210
Characterization of mtr genes in H. ducreyi. Previous work with N. gonorrhoeae has 211
shown that CCCP-mediated inactivation of the MTR transporter increases sensitivity to APs 212 (46). A search of the H. ducreyi genome for possible RND pumps, such as MTR, revealed a 213 locus encoding two putative RND efflux components. HD1513 encodes a predicted protein that 214 is 31% identical and 37% similar to the N. gonorrhoeae MtrD inner membrane protein; directly 215 upstream is HD1512, which encodes a putative RND efflux membrane fusion protein that is 29% 216 identical and 44% similar to N. gonorrhoeae MtrC, which we termed mtrC (Fig. 2) and round, while the 35000HPmtrC(pLSSK) mutant colonies were translucent, rough, and 234 irregularly shaped (Fig 3A panels 1 and 2 , respectively). This colony morphology was restored 235 to wild-type when complemented in trans with mtrC (Fig 3A panel 3) . OMP profiles showed 236 two changes in 35000HPmtrC compared with 35000HP. 35000HPmtrC lacked a 28 kDa band 237 and showed increased intensity in a 43 kDa band (Fig. 3B ). This altered OMP profile was 238 reminiscent of the OMP profile of a cpxA mutant, which does not express the 28 kDa DsrA and 239 overexpresses the 43 kDa OmpP2B protein (28, 48). We thus used western blot analysis to 240 confirm that DsrA and OmpP2B were the proteins with altered expression in 35000HPmtrC (Fig.  241   3C) . DsrA was not detected in whole cell lysates of 3500HPmtrC but was restored to wild-type 242 levels when 35000HPmtrC was trans-complemented with mtrC ( Fig. 3C upper panel, lanes 1-3) . 243
As expected, DsrA expression was not detected in the dsrA mutant FX517 nor in the cpxA 244 mutant ( 35000HP∆cpxA showed levels of OmpP2B that were elevated 6.8 and 6.0 fold, respectively, 249 compared to 35000HP (Fig. 3C lower panel, lanes 2 and 5) . 250
DsrA is required for H. ducreyi survival in human serum (17). Because DsrA expression 251 was undetectable in 35000HPmtrC, we tested the mtrC mutant for serum resistance. 252 35000HPmtrC(pLSSK) was as sensitive as the dsrA mutant FX517 to serum-mediated killing 253 and significantly more sensitive than wild-type 35000HP(pLSSK) (p = 0.005) (Fig. 3D ). This 254 serum sensitive phenotype was fully complemented in 35000HPmtrC(pmtrC) (Fig.3D) . 255
Deletion of mtrC in 35000HP activated the two-component regulator CpxRA system. 256
Recent studies showed that the CpxRA two-component regulator in H. ducreyi regulates 257 expression of DsrA and OmpP2B (28, 48). Sequence analysis showed no changes in the 258 predicted promoter regions for dsrA and ompP2B in 35000HPmtrC (data not shown). We thus 259 hypothesized that the Cpx regulon is activated in the mtrC mutant. We tested this hypothesis by 260 examining mRNA expression levels of selected Cpx-regulated genes, including dsrA, ompP2B, 261 and two additional genes known to be either upregulated (HD0281) or downregulated (HD1155) 262 by activation of CpxRA (28). HD0281 encodes the putative major fimbrial subunit FimA, and 263 HD1155 encodes LspB, which is required for secretion of the antiphagocytic factors LspA1 and 264 LspA2 (29, 52). qRT-PCR analysis showed that, relative to 35000HP, the mtrC mutant had 265 increased transcriptional levels of fimA and ompP2B and decreased mRNA levels of lspB and 266 dsrA (Fig. 4) . These data confirmed that the CpxRA regulon was activated in 35000HPmtrC. 267
We examined the colony morphology of 35000HP∆cpxA, in which the Cpx regulon is 268 constitutively active, to determine whether CpxRA activation accounted for the altered 269 To assess the contribution of CpxRA activation to LL-37 sensitivity in the mtrC mutant, 281
we tested 35000HP∆cpxA alongside 35000HP and 35000HPmtrC for susceptibility to LL-37. 282
Both mutants were more sensitive than 35000HP to LL-37 at a concentration of 4 µg/ml ( Fig. 283 5B); however, only the mtrC mutant was significantly more sensitive than the parent to LL-37 284 concentrations from 0.5-2 µg/ml. At these concentrations, the mtrC mutant was more sensitive 285 than the cpxA mutant (Fig. 5B , double asterisks). 35000HP∆cpxR, in which the Cpx regulon is 286 constitutively inactive (29), showed no significant difference from 35000HP in survival of LL-37 287 at concentrations ranging from 0.2 to 20 µg/ml (data not shown). Together, these data suggest 288 that, although activation of CpxRA causes increased sensitivity to LL-37, the MTR transporter 289 itself independently contributes to LL-37 resistance. 290
Because 35000HP∆cpxA exhibited increased sensitivity to LL-37, and we previously 291 identified a role for the H. ducreyi Sap transporter in LL-37 resistance, we used qRT-PCR to 292 determine whether sap gene expression was affected in the cpxA mutant. Both sapA, the first 293 structural gene in the sap operon, and the genetically unlinked sapF were expressed at wild-type 294 and 1.3 ± 0.3, respectively. Similarly, expression of mtrC was not affected by deletion of cpxA 296
(1.1 ± 0.2). Thus, the increased sensitivity of 35000HP∆cpxA to LL-37 was not attributable to 297 changes in expression of either the Sap or MTR transporters. 298
The MTR transporter contributes to β β β β-defensin resistance. We next tested 299 difference in sensitivity to HBD-3, and 35000HP∆cpxA showed no difference at HBD-3 306 concentrations of 0.2 -2 µg per ml (Fig. 6D) . At 20 µg HBD-3 per ml, there was a trend toward 307 increased susceptibility of the cpxA mutant to HBD-3 (p = 0.08) (Fig. 6D ). Taken together, the 308 data suggest that the MTR transporter, rather than activation of the CpxRA system, is likely the 309 major determinant of resistance to HBD-3 in H. ducreyi. 310
The MTR transporter has little effect on α α α α-defensin resistance. The susceptibility of 311 35000HP to HNP-2 was not affected when the proton motive force was dissipated with CCCP 312 (data not shown), suggesting that the MTR system may not play a role in α-defensin resistance. 313
We assayed the mtrC mutant for sensitivity to three α-defensins, including HNP-1, HNP-2, and 314 HD-5. At concentrations of 0.2-2 µg/ml, both the parent and mtrC mutant strains were fully 315 resistant to all three α-defensins (data not shown). At a concentration of 20 µg/ml, the mtrC 316 mutant showed a decreased survival of 10-15% against two α-defensins (Table 3) . We also 317 on November 1, 2017 by guest http://iai.asm.org/ Downloaded from examined the susceptibility of 35000HP∆cpxA to HNP-1 and HNP-2 and found no increased 318 sensitivity when compared with 35000HP (Table 3 and data not shown). We concluded that the 319 MTR transporter plays only a minor role in α-defensin resistance and that the CpxRA system 320 does not appear to control a major mechanism of α-defensin resistance. 321
The MTR transporter confers PMF-dependent AP resistance in H. ducreyi. Our AP 322 susceptibility assays demonstrated that, while activation of the Cpx system may affect one or 323 more AP resistance mechanisms, loss of MtrC had a greater effect on AP resistance than did loss 324 of CpxA (Figs. 5-6). We next examined whether the mtrC or cpxA mutants retained the PMF-325 dependent AP resistance mechanism observed in 35000HP (Fig. 1) . 35000HP, 35000HPmtrC, 326 and 35000HP∆cpxA were treated with either DMSO alone or CCCP in DMSO, followed by 327 either LL-37 (Fig. 7A ) or HBD-3 (Fig. 7B) . As expected, CCCP pretreatment significantly 328 enhanced sensitivity of the parent strain to both APs. Similar results were obtained with 329 35000HP∆cpxA, indicating that Cpx-mediated AP resistance is not PMF-dependent. In contrast, 330 pretreatment with CCCP had no significant effect on the AP sensitivity of 35000HPmtrC (Fig.  331 7), indicating that, in H. ducreyi, the MTR transporter is likely the main AP resistance 332 mechanism driven by the PMF. isolates contained the identical mtrC allele, which varied at 27 bp from the 35000HP mtrC allele, 344 leading to a predicted full-length protein with 10 a.a. substitutions compared with MtrC from 345
35000HP. 346
We have previously shown that LL-37 and β-defensin resistance in the class II strain 347 CIP542 ATCC is similar to that of 35000HP (34), suggesting that the class II mtrC allele is 348 functional. The finding of a truncated mtrC allele in two class I clinical isolates raised the 349 question of whether these isolates would exhibit increased sensitivity to APs and constitutive 350 activation of CpxRA, as was observed in 35000HPmtrC. We therefore compared strain 6644 351 with 35000HP for LL-37 and HBD-3 resistance, serum resistance, and expression of CpxRA-352 regulated outer membrane proteins. Both strains were grown at 30°C with 10% CO 2 , which 353 allowed propagation of 6644; strain 82-029362 did not grow sufficiently for use in these assays. 354
Compared with 35000HP, strain 6644 was more sensitive to both LL-37 (Fig. 8B ) and HBD-3 355 (Fig. 8C) . We noted that 35000HP was slightly more resistant to HBD-3 than seen in previous 356 assays, which may be due to the modified growth conditions. To assay for CpxRA activation, 357 we examined expression of DsrA and OmpP2B by western blot. Our results indicated that DsrA 358 and OmpP2B were expressed at similar levels in 6644 and 35000HP (Fig. 8D) 
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In this study, we defined a PMF-dependent mechanism of AP resistance in H. ducreyi. 365 CCCP acts as a proton uncoupler that can inhibit transporters such as the RND, major facilitator 366 superfamily (MFS), and multidrug and toxic compound extrusion (MATE) families (31). Our 367 data show that H. ducreyi utilizes a PMF-dependent mechanism for LL-37 and HBD-3 resistance 368 but not for resistance to α-defensin HNP-2. Experiments by Shafer et al. showed a similar 369 response for N. gonorrhoeae exposed to AP and CCCP, and the major contributor to this 370 phenotype was the MTR transporter (46). We identified an H. ducreyi homolog of MTR and 371 inactivated the transporter by deletion of mtrC. Although the loss of mtrC activated the CpxRA 372 regulon, the mtrC mutant was more sensitive than a cpxA mutant to LL-37 and HBD-3. Addition 373 of CCCP to the mtrC mutant did not affect AP resistance, indicating that this mutant had lost the 374 PMF-dependent AP resistance mechanism. In contrast, exposure to CCCP increased the 375 sensitivity of a cpxA mutant to APs, indicating that the cpxA mutant retained PMF-dependent AP 376
resistance. These data demonstrate that the PMF-dependent AP resistance in H. ducreyi is 377 mediated by the MTR homolog. 
fully complemented in trans by the intact mtrC gene (Fig. 3) , confirming that the phenotypic 396 changes were not due to secondary mutations in 35000HPmtrC. Rather, our data show that 397 mutation of mtrC activated the two-component CpxRA system. In other organisms, the CpxRA 398 system is activated in response to envelope stress, although its trigger in H. ducreyi is unclear 399 The mtrC mutant is more sensitive than the parent strain to cathelicidin and β-defensin 413 classes of human APs. Because the CpxRA system was activated in the mtrC mutant, we 414 examined the AP resistance phenotype of cpxA and cpxR mutants in order to determine the 415 contributions of MTR and the Cpx system to the AP resistance phenotype of 35000HPmtrC. 416
Inactivation of cpxR had no effect on AP resistance (Fig. 6D, data not shown) . Deletion of cpxA 417 led to reduced resistance against LL-37 (Figs. 5B, 7A) but had little effect on HBD-3 resistance 418 (Figs. 6D, 7B) , suggesting that the CpxRA system may affect expression of a mechanism for 419 resistance to LL-37 but likely does not play a major role in β-defensin resistance. When assayed 420 side-by-side, the mtrC mutant was significantly less resistant than the cpxA mutant to LL-37 421 (Fig. 5B) , suggesting that the loss of MTR likely plays a larger role than Cpx activation in the 422 increased LL-37 resistance phenotype of 35000HPmtrC. A distinction between MTR-mediated 423
and CpxRA-mediated AP resistance was also observed by addition of the PMF-uncoupler CCCP 424 to AP sensitivity assays (Fig. 7) . While the cpxA mutant responded to loss of PMF by becoming 425 more sensitive to LL-37 and HBD-3, CCCP had no effect on the AP sensitivity of the mtrC 426 mutant, demonstrating that the mtrC mutant, but not the cpxA mutant, had lost the PMF-427 dependent AP resistance mechanism. We thus conclude that the H. ducreyi MTR transporter 428 itself confers resistance to LL-37 and β-defensins. 429
It is unclear how the CpxRA system affects LL-37 resistance in H. ducreyi. We have 430 previously identified the Sap transporter as a virulence factor reducing sensitivity to LL-37 (35). 431
In the current study, we identified the MTR transporter as a second mechanism of LL-37 432 strain 6644, which carries the naturally occurring mtrC mutation, showed increased sensitivity to 470 LL-37 and HBD-3 compared with 35000HP, mirroring our findings with the engineered mtrC 471 deletion. Due to poor growth, we were not able to test the AP susceptibility of 82-029362, the 472 other isolate harboring the natural mtrC mutation. The lack of a functional MTR system in two 473 H. ducreyi isolates might indicate that the transporter is dispensable for virulence. However, 474 unlike 35000HP, the passage history of these two isolates and whether they have retained the 475 ability to infect humans is unknown. Based on expression levels of outer membrane proteins 476 
